An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome.
Kolevzon A, Levy T, Barkley S, Bedrosian-Sermone S, Davis M, Foss-Feig J, Halpern D, Keller K, Kostic A, Layton C, Lee R, Lerman B, Might M, Sandin S, Siper PM, Sloofman LG, Walker H, Zweifach J, Buxbaum JD.
Kolevzon A, et al.
HGG Adv. 2022 Aug 27;3(4):100138. doi: 10.1016/j.xhgg.2022.100138. eCollection 2022 Oct 13.
HGG Adv. 2022.
PMID: 36119806
Free PMC article.